Cargando…

Impact of Coronary Atherosclerosis on Bioresorbable Vascular Scaffold Resorption and Vessel Wall Integration

The integration of the Absorb bioresorbable vascular scaffold (BVS) into the arterial wall has never been tested in an in vivo model of atherosclerosis. This study aimed to compare the long-term (up to 4 years) vascular healing responses of BVS to an everolimus-eluting metallic stent in the familial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yanping, Ferrone, Marco, Wang, Qing, Perkins, Laura E.L., McGregor, Jennifer, Redfors, Björn, Zhou, Zhipeng, Rapoza, Richard, Conditt, Gerard B., Finn, Aloke, Virmani, Renu, Kaluza, Grzegorz L., Granada, Juan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	PRECLINICAL RESEARCH
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315185/ https://www.ncbi.nlm.nih.gov/pubmed/32613147 http://dx.doi.org/10.1016/j.jacbts.2020.04.005

Ejemplares similares

Early scaffold strut coverage in ultra-high molecular weight amorphous PLLA sirolimus-eluting bioresorbable scaffolds: impact of strut thickness assessed in normal porcine coronary arteries
por: Gąsior, Paweł, et al.
Publicado: (2020)

Downstream Paclitaxel Released Following Drug-Coated Balloon Inflation and Distal Limb Wound Healing in Swine
por: Granada, Juan F., et al.
Publicado: (2021)

New insights into the role of iron in inflammation and atherosclerosis
por: Cornelissen, Anne, et al.
Publicado: (2019)

Transcatheter-Delivered Expandable Bioresorbable Polymeric Graft With Stenting Capacity Induces Vascular Regeneration
por: Duijvelshoff, Renee, et al.
Publicado: (2020)

Differential Leaflet Remodeling of Bone Marrow Cell Pre-Seeded Versus Nonseeded Bioresorbable Transcatheter Pulmonary Valve Replacements
por: Fioretta, Emanuela S., et al.
Publicado: (2019)

Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies
por: Gogas, Bill D., et al.
Publicado: (2011)

Comparison of a Drug‐Free Early Programmed Dismantling PDLLA Bioresorbable Scaffold and a Metallic Stent in a Porcine Coronary Artery Model at 3‐Year Follow‐Up
por: Yahagi, Kazuyuki, et al.
Publicado: (2017)

Understanding the Impact of Stent and Scaffold Material and Strut Design on Coronary Artery Thrombosis from the Basic and Clinical Points of View
por: Sakamoto, Atsushi, et al.
Publicado: (2018)

Cause of Stent Failure in Patients on Hemodialysis
por: Sato, Yu, et al.
Publicado: (2020)

The pathological images of cholesterol crystals piercing into fibrous cap in a patient with acute coronary syndrome
por: Konishi, Takao, et al.
Publicado: (2023)

Bioresorbable vascular scaffolds for LMCA with double vessel disease under IVUS guidance
por: Kasturi, Sridhar, et al.
Publicado: (2015)

IN.PACT™ Admiral™ drug-coated balloons in peripheral artery disease: current perspectives
por: Torii, Sho, et al.
Publicado: (2019)

Proteolysis of Von Willebrand Factor Influences Inflammatory Endothelial Activation and Vascular Compliance in Atherosclerosis
por: Ozawa, Koya, et al.
Publicado: (2020)

Paclitaxel Drug-Coated Balloon Angioplasty Suppresses Progression and Inflammation of Experimental Atherosclerosis in Rabbits
por: Chowdhury, Mohammed M., et al.
Publicado: (2020)

Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis
por: Morton, Jamie, et al.
Publicado: (2018)

Serial Coronary Imaging of Early Atherosclerosis Development in Fast-Food-Fed Diabetic and Nondiabetic Swine
por: van Ditzhuijzen, Nienke S., et al.
Publicado: (2016)

Apolipoprotein E Deficiency Increases Remnant Lipoproteins and Accelerates Progressive Atherosclerosis, But Not Xanthoma Formation, in Gene-Modified Minipigs
por: Shim, Jeong, et al.
Publicado: (2017)

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE(−/−) and LDLr(−/−) Mice by a Mechanism That Includes Inflammatory Pathways
por: Rakipovski, Günaj, et al.
Publicado: (2018)

Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A
por: Nordlohne, Johannes, et al.
Publicado: (2018)

Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa–PAR2-Mediated Autophagy Suppression
por: Ito, Yusuke, et al.
Publicado: (2021)

Bioresorbable scaffolds: everything resolved?
por: Appelman, Yolande
Publicado: (2015)

Chronic myocardial and coronary arterial effects of intracoronary supersaturated oxygen therapy in swine with normal and ischemic-reperfused myocardium
por: Kaluza, Grzegorz L., et al.
Publicado: (2022)

1-Year Patency of Biorestorative Polymeric Coronary Artery Bypass Grafts in an Ovine Model
por: Ono, Masafumi, et al.
Publicado: (2022)

Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding
por: N. Kharlamov, M.D., Alexander
Publicado: (2016)

Significance of Intraplaque Hemorrhage for the Development of High-Risk Vulnerable Plaque: Current Understanding from Basic to Clinical Points of View
por: Sakamoto, Atsushi, et al.
Publicado: (2023)

Can Paclitaxel Coated Balloons Have a Deep Impact on Critical Limb Ischemia?
por: Parikh, Sahil A., et al.
Publicado: (2021)

Bioresorbable scaffolds for percutaneous coronary interventions
por: Gogas, Bill D.
Publicado: (2014)

Bioresorbable Polymeric Scaffold in Cardiovascular Applications
por: Toong, Daniel Wee Yee, et al.
Publicado: (2020)

Bioactive Extracellular Matrix Scaffold Promotes Adaptive Cardiac Remodeling and Repair
por: Mewhort, Holly E.M., et al.
Publicado: (2017)

In Situ Heart Valve Tissue Engineering: Is Scaffold Structural Biomimicry Overrated?
por: Mela, Petra, et al.
Publicado: (2020)

Longitudinal dynamics of circulating miRNAs in a swine model of familial hypercholesterolemia during early atherosclerosis
por: Namous, Hadjer, et al.
Publicado: (2023)

Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model
por: Campos, Carlos M., et al.
Publicado: (2015)

Multimodality intravascular imaging of bioresorbable vascular scaffolds implanted in vein grafts
por: Roleder, Tomasz, et al.
Publicado: (2019)

Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
por: Brugaletta, Salvatore, et al.
Publicado: (2011)

Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus‐Eluting Bioresorbable Vascular Scaffold
por: Kraak, Robin P., et al.
Publicado: (2015)

Bioresorbable vascular scaffolds in saphenous vein grafts (data from OCTOPUS registry)
por: Roleder, Tomasz, et al.
Publicado: (2015)

The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis
por: Habib, Anwer, et al.
Publicado: (2014)

Bioresorbable scaffolds in the treatment of coronary artery disease
por: Zhang, Yaojun, et al.
Publicado: (2013)

Vascular restoration therapy and bioresorbable vascular scaffold
por: Wang, Yunbing, et al.
Publicado: (2014)

Bioresorbable vascular scaffolds: between promises and reality
por: Montone, Rocco A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ugeo7ath3v427d776o7pkqb0d6